InvestorsHub Logo
Followers 138
Posts 23418
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Wednesday, 01/24/2024 9:23:46 AM

Wednesday, January 24, 2024 9:23:46 AM

Post# of 465123
Muscarinic receptor modulators for schizophrenia attract multibillion-dollar attention
By Asher Mullard

Bristol Myers Squibb committed US$14 billion to buy Karuna Therapeutics, just weeks after AbbVie paid $8.7 billion for Cerevel Therapeutics. The acquired muscarinic receptor modulators stand to become the first novel type of schizophrenia drugs to make it to market in decades.

https://www.nature.com/articles/d41573-024-00015-5

Anavex 3-71 is muscarinic receptor agonist and a sigma-1 agonist.

https://www.anavex.com/post/anavex-life-sciences-announces-phase-2-clinical-trial-anavex-3-71-schizophrenia

🇺🇲🇺🇦🙄

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News